EICHORCondition: Adolescent Cancer Survivors · Childhood Cancer Survivors · Anxiety · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Interested? Contact the study team ↓
In France today, it is estimated that one in 850 people aged between 20 and 45 has been cured of cancer in childhood. Some descriptive studies have established that cancer diagnosis and treatment can affect psychological health, with an increased risk of depression, post-traumatic stress, anxiety and suicidal risk. A French study published by our team in 2015 and 2020 also showed that, as adults, 40% of former pediatric cancer patients experienced symptoms of anxiety, a rate significantly higher than that of the general French population (25%). While it is well established that it is essential to detect the onset of anxiety-depressive disorders and, if necessary, to set up conventional psychological treatment (CPT), few studies have sought to show the benefit of complementing this conventional CPT with mind-body therapies (MBT) in the post-cancer pediatric setting. This project aims to determine the benefit of mind-body therapies (hypnosis and relaxation) as a complement to conventional psychological treatment (CPT) in the management of anxiety in children, adolescents and young adults in remission from pediatric cancer or leukemia.
This description comes directly from the study's public registry record.
Claire BERGER, MD · 04.77.12.79.37 · claire.berger@chu-st-etienne.fr
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: HARMONY KIDS * Patients aged at least 7 and under 15 at the time of inclusion, diagnosed with pediatric cancer, * Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion * Patients receiving follow-up care after pediatric cancer at one of the participating centers, * Patients with anxiety disorders (SCARED-R score ≥ 31) * Patients affiliated with or eligible for social security, * Patients and their parents (or legal guardians) who have received informed consent about the study and co-signed, with the investigator, a consent form to participate in the study. HARMONY AYA * Patients aged at least 15 and no more than 25 years old at the time of inclusion, diagnosed with pediatric cancer before the age of 18, * Patients considered to be in complete remission from pediatric cancer, whose intensive treatment ended at least 3 months prior to inclusion, * Patients receiving follow-up care after pediatric cancer at one of the participating centers, * Patients with anxiety disorders (HADS-Anxiety score ≥ 8) * Patients affiliated with or eligible for social security, * For adult patients: patients who have received informed information about the study and have co-signed, with the investigator, a consent form to participate in the study, * For minors: patients and their parents (or legal guardians) who have received informed consent about the study and have co-signed, with the investigator, a consent form for participation in the study. Exclusion criteria: For HARMONY-Kids: * Presence of active suicidal ideation and/or need for urgent psychiatric care, * Patient experiencing a cancer relapse, * Refusal to participate, * Pregnant women, women in labor, or breastfeeding mothers, * Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research, * Individuals subject to legal guardianship or conservatorship, or those unable to give informed consent For HARMONY-AYA: * Presence of active suicidal ideation and/or need for urgent psychiatric care, * Patients experiencing a cancer relapse, * Refusal to participate, * Pregnant women, women in labor, or breastfeeding mothers, * Individuals deprived of their liberty, hospitalized without consent, or hospitalized for purposes other than research, * Adults subject to legal guardianship or conservatorship, or unable to give informed consent.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Centre Hospitalier Universitaire Caen Normandie | Caen, France | Not Yet Recruiting |
| Centre Hospitalier Universitaire Grenoble Alpes | Grenoble, France | Not Yet Recruiting |
| Institut d'Hématologie et d'Oncologie Pédiatrique | Lyon, France | Not Yet Recruiting |
| Centre Hospitalier Universitaire | Rouen, France | Not Yet Recruiting |
| CENTRE HOSPITALIER UNIVERSITAIRE - site NORD | Saint-Etienne, France | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07380672